Related Experiment Videos
A mouse model for poliovirus neurovirulence identifies mutations that attenuate the virus for humans
Abstract:
A mutation in the genome of poliovirus type 3 that is known to reduce neurovirulence in humans similarly reduces neurovirulence in mice when incorporated into a mouse-adapted-human poliovirus recombinant. Viral recombinants with a uracil at nucleotide position 472 in the 5'-noncoding regions of their genomes are unable to replicate in the mouse brain. Viral recombinants with a cytosine at this position are neurovirulent in mice. Neurovirulence of poliovirus in mice may therefore prove to be a useful indicator of the genetic stability of new attenuating mutations created by site-directed mutagenesis.
Insights
A specific poliovirus mutation reduces disease severity in humans and mice. This genetic change at nucleotide 472 impacts viral replication in the mouse brain, offering a model for studying poliovirus attenuation.
Area of Science:
- Virology
- Genetics
- Neuroscience
Background:
- Poliovirus type 3 causes neurovirulence in humans.
- Site-directed mutagenesis is used to create attenuated poliovirus strains.
- Mouse models are crucial for studying viral pathogenesis.
Purpose of the Study:
- To investigate the effect of a specific poliovirus type 3 mutation on neurovirulence in a mouse model.
- To determine if mouse neurovirulence can serve as an indicator for poliovirus genetic stability.
Main Methods:
- Generation of mouse-adapted-human poliovirus recombinants.
- Site-directed mutagenesis to introduce a uracil or cytosine at nucleotide position 472.
- Assessment of viral replication and neurovirulence in the mouse brain.
Main Results:
- A uracil at nucleotide position 472 abolished viral replication in the mouse brain.
- A cytosine at nucleotide position 472 resulted in neurovirulence in mice.
- The mutation's effect on neurovirulence was consistent between humans and mice.
Conclusions:
- Mouse neurovirulence is a reliable indicator for the genetic stability of attenuating poliovirus mutations.
- The nucleotide 472 position in the 5'-noncoding region is critical for poliovirus neurovirulence in mice.
- This study provides a valuable model for developing safer poliovirus vaccines.